The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of a panel of cell-cycle progression genes for improved risk stratification in a contemporary radical prostatectomy cohort.
Matthew R. Cooperberg
No relevant relationships to disclose
Jeffrey Simko
No relevant relationships to disclose
Janet E. Cowan
No relevant relationships to disclose
Julia E. Reid
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Satish Bhatnagar
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Alexander Gutin
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jerry S. Lanchbury
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Steven Stone
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Peter Carroll
Honoraria - Myriad Genetics
Research Funding - Abbott Laboratories; Myriad Genetics